CVS Health's Annual Impact in Connecticut

May 7, 2026 9:00 AM

Originally published in the CVS Health National Economic Impact ReportWith more than 9,000 locations and 300,000 employees, CVS Health is a driving force in the American economy, delivering $474 billion in economic impact nationwide.As one of the country's largest private employers, we're making health care more affordable and accessible for you and your family.Discover how our economic footprint benefits communities across the U.S: creating...

Read more

P-n-T Data Corp. Wins "Best Overall Healthcare Cybersecurity Solution" Designation in 2026 MedTech Breakthrough Awards

May 7, 2026 9:00 AM

P-n-T Data Corp., a provider of managed services for healthcare data sharing, today announced that it has been selected as winner of the "Best Overall Healthcare Cybersecurity Solution" award in the 10th annual MedTech Breakthrough Awards. The program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies and products in the global digital health and...

Read more

Juniper Advisory Announces Three New Partners

May 7, 2026 9:00 AM

Juniper Advisory, a leading independent investment banking firm specializing in nonprofit hospital mergers and acquisitions, is pleased to announce the promotion of three Partners. As an employee-owned firm, Juniper remains committed to fostering a culture of experienced objectivity and alignment with client interests.The newly promoted partners include Brent McDonald, Farley Reardon and Casey Webb. Each brings decades of experience advising...

Read more

UNC Health Selects Evidently as its Clinical Data Intelligence Partner for an Enterprise Deployment Across Hospitals and Clinics in Triangle Region of North Carolina

May 7, 2026 8:00 AM

Evidently, the leading Clinical Data Intelligence company, today announced that UNC Health selected its platform for UNC Health hospitals and clinics in the Triangle Region of North Carolina.UNC Health's decision follows a 12-week pilot involving 100 users including clinicians, clinical documentation specialists and physician leaders. Pilot participants evaluated Evidently's effectiveness in synthesizing information from large and complex...

Read more

UniDoc to Update and Relaunch Legacy eHealth Systems with Pawnee Mental Health Services Across Rural Kansas

May 7, 2026 7:30 AM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") is pleased to announce that Pawnee Mental Health Services ("Pawnee"), a provider of mental health, substance use recovery and crisis services across 10 north central Kansas counties, has purchased UniDoc Connect software licenses to trial and relaunch eHealth equipment across its rural Kansas office network. Pawnee's account originated with AMD Telemedicine which...

Read more

Nurses Week Report: AI Documentation Must Reduce Charting Burden, Not Add Risk | Black Book Research

May 7, 2026 7:10 AM

In recognition of Nurses Week 2026, Black Book Research today released a new special report, "The Nurse Documentation and AI Readiness Gap," finding that registered nurses are open to artificial intelligence documentation support, but only if the technology reduces redundant charting, preserves nurse control, and does not shift legal or audit risk to bedside clinicians.The vendor-agnostic report is based on a survey of 118 registered nurse...

Read more

Beyond Function: Eydology Redefines Professional Identity with High-Style, Affordable Prescription Glasses for the Hybrid Work Era

May 7, 2026 2:25 AM

For many professionals in 2026, the workday begins on a screen-but rarely ends there. A morning Zoom call can quickly be followed by a client meeting across town, a midday coffee run, and an evening networking event. As hybrid work continues to reshape professional environments, affordable prescription glasses are evolving beyond a basic necessity into a visible extension of personal and professional identity. Eyewear brand EYDOLOGY is...

Read more

Spago Nanomedical Interim Report January-March 2026

May 7, 2026 2:20 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)JANUARY - MARCH IN BRIEFNet sales for the quarter amounted to KSEK 22 (KSEK 338)The loss for the quarter amounted to KSEK -6,798 (KSEK -7,435)Operating expenses for the quarter amounted to KSEK -7,967 (KSEK -8,964)Earnings per share, before and after dilution, for the quarter amounted to SEK -0.01 (SEK -0. 02)Cash and cash equivalents at the end of the quarter amounted to KSEK 25,923 (KSEK...

Read more

As Wall Street Celebrates "Marijuana Rescheduling," the Real Story Is Emerging: The DEA's Own Final Rules Collide With the Political Hype

May 7, 2026 1:40 AM

While marijuana stock promoters and political commentators celebrate the idea of federal cannabis rescheduling as if legalization is imminent, a far more dangerous reality is beginning to surface behind closed doors in Washington: The United States government may now be trapped inside its own regulatory contradictions.For nearly a decade, companies like MMJ International Holdings and its subsidiary MMJ BioPharma Cultivation followed the federal...

Read more

Action Behavior Centers Marks Autism Acceptance Month with Nationwide Celebrations and a Renewed Commitment to Inclusion

May 6, 2026 7:40 PM

Action Behavior Centers, a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), reflected on a month of meaningful activities, family celebrations, and community engagement held throughout April in recognition of Autism Acceptance Month.April has long been recognized as Autism Acceptance Month, a time for schools, organizations, and communities to promote inclusion...

Read more

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

May 6, 2026 5:15 PM

Moderna, Inc. (NASDAQ:MRNA) today announced a publication in the New England Journal of Medicine of the positive Phase 3 study results evaluating mRNA-1010, its vaccine candidate for seasonal influenza. The peer-reviewed article summarizes the safety and efficacy data from Moderna's Phase 3 study (P304) evaluating the relative vaccine efficacy (rVE) of mRNA-1010 against influenza illness compared to a licensed standard-dose seasonal influenza...

Read more

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity

May 6, 2026 5:05 PM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the first quarter ended March 31, 2026."Delivering 35% growth and achieving record year-over-year revenue for the 21st consecutive quarter reflects the consistency of our execution and the growing demand for...

Read more

Better Addiction Care Joins Communities Around the Country in Celebrating Mental Health Awareness Month

May 6, 2026 4:20 PM

Better Addiction Care, a leading informational resource and web guide connecting visitors with trusted mental health and addiction treatment providers, is highlighting Mental Health Awareness Month 2026. This year's campaign focuses on raising awareness, reducing stigma, and increasing access to treatment.To amplify the momentum of this national effort, Better Addiction Care is proud to announce its continued commitment to helping people find...

Read more

Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026

May 6, 2026 4:05 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its third quarter of fiscal 2026, after the market close on Wednesday, May 13, 2026. The Company has scheduled a conference call and webcast that same day, Wednesday, May 13,...

Read more

Avel eCare Hosts National Emergency Airway Course, Earning Top Marks from Clinicians Across the Country

May 6, 2026 3:50 PM

Avel eCare welcomed emergency clinicians from across the country to Sioux Falls for its annual Emergency Airway Training Program, a two day, immersive course focused on one of the most critical and high risk emergency procedures: advanced airway management.Powered by The Difficult Airway Course™, the program combines evidence based instruction with intensive hands on training designed to help physicians, advanced practice providers, nurses, and...

Read more

Advanced Urology Alpharetta Ambulatory Surgery Center Named Among 2026 Best Ambulatory Surgery Centers by U.S. News & World Report

May 6, 2026 3:25 PM

Advanced Urology today announced that its Alpharetta ambulatory surgery center has been named among the 2026 Best Ambulatory Surgery Centers by U.S. News & World Report, a recognition that places the facility in the top tier of outpatient surgical centers nationwide.The 2026 ratings, released by U.S. News in March, evaluated more than 4,400 ambulatory surgery centers across the country and recognized 911 facilities, or roughly 21 percent, as...

Read more

Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness

May 6, 2026 10:35 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the introduction of Fort18™ in the United States - a men's sexual stamina supplement formulated with a proprietary blend of botanical extracts and nutrients that has been evaluated in published clinical research.Fort18™ is the latest addition to the Company's "18 Series," entering a large and growing...

Read more

Nurses Week Report: FBI Cyber Warning Puts Hospital Nurses' Downtime Readiness in Focus

May 6, 2026 9:35 AM

Black Book Research today released findings from a national survey of 480 registered nurses examining hospital cyber-downtime readiness from the bedside perspective, as National Nurses Week begins amid heightened federal concern over cyber risks facing hospitals and health systems.The report, "The Nurse Cyber-Downtime Gap" reframes hospital cybersecurity as a clinical-continuity and patient-safety issue, focusing on whether nurses can safely...

Read more

Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)

May 6, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") family company Napo Pharmaceuticals Inc., announced that the Company recently held a preliminary discussion with the Division of Gastroenterology at U.S. Food and Drug Administration (FDA) to evaluate the possibility of a Breakthrough Therapy Designation (BTD) for oral liquid crofelemer as an adjunctive therapy to PS for the treatment of pediatric patients with intestinal failure (IF) due to...

Read more

Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection

May 6, 2026 8:05 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO) today reported new clinical results from its RAINIER frontline acute myeloid leukemia (AML) trial. The Company is on track to complete the Phase 1b dose-optimization trial and select the recommended Phase 2 dose (RP2D) this year. As with the current study, the Phase 2 trial will dose mipletamig in combination with venetoclax and azacitidine.Across 31 evaluable frontline AML patients treated to date...

Read more